ABBOTT REALTIME HBV

Hepatitis Viral B Dna Detection

FDA Premarket Approval P080026 S016

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for two changes to the application specification files to extend the chiller delay timer and change the conductivity setting for the detection of rna wash2 liquid.

DeviceABBOTT REALTIME HBV
Classification NameHepatitis Viral B Dna Detection
Generic NameHepatitis Viral B Dna Detection
ApplicantABBOTT MOLECULAR, INC.
Date Received2015-07-29
Decision Date2015-10-09
PMAP080026
SupplementS016
Product CodeMKT
Advisory CommitteeMicrobiology
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address ABBOTT MOLECULAR, INC. 1300 East Touhy Avenue des Plaines, IL 60018

Supplemental Filings

Supplement NumberDateSupplement Type
P080026Original Filing
S024 2021-02-05 30-day Notice
S023 2020-11-16 30-day Notice
S022 2019-04-10 30-day Notice
S021 2017-06-27 135 Review Track For 30-day Notice
S020 2016-12-01 30-day Notice
S019 2016-11-16 30-day Notice
S018 2016-10-27 30-day Notice
S017 2016-03-28 30-day Notice
S016 2015-07-29 Real-time Process
S015
S014 2015-03-26 30-day Notice
S013 2014-11-10 30-day Notice
S012 2014-10-24 30-day Notice
S011 2013-11-12 30-day Notice
S010 2013-10-21 30-day Notice
S009 2013-07-23 30-day Notice
S008 2013-07-11 Real-time Process
S007 2013-05-01 30-day Notice
S006 2013-02-15 Normal 180 Day Track
S005 2012-12-26 30-day Notice
S004 2012-10-04 30-day Notice
S003 2012-04-02 135 Review Track For 30-day Notice
S002 2011-07-01 135 Review Track For 30-day Notice
S001

NIH GUDID Devices

Device IDPMASupp
00884999046603 P080026 000
00884999042667 P080026 016

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.